Risk Minimisation materials: Arava (leflunomide) – all strengths

Materials include a prescriber’s checklist to help minimise the risk of hepatotoxicity, haematotoxicity, infections and serious birth defects when administered during pregnancy and a patient information leaflet.

Sanofi UK